Works by Hammerman, Ariel

Results: 25

Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 5, p. 553, doi. 10.1007/s10198-013-0544-6

By:

Gavious, Arieh;
Greenberg, Dan;
Hammerman, Ariel;
Segev, Ella

Publication type:

Article

Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis.

Published in:

American Journal of Cardiovascular Drugs, 2023, v. 23, n. 3, p. 323, doi. 10.1007/s40256-023-00578-5

By:

Alnsasra, Hilmi;
Tsaban, Gal;
Solomon, Adam;
Khalil, Fouad;
Aboalhasan, Enis;
Weinstein, Jean Marc;
Azuri, Joseph;
Hammerman, Ariel;
Arbel, Ronen

Publication type:

Article

Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 6, p. 677, doi. 10.1007/s40256-022-00543-8

By:

Tsaban, Gal;
Alnsasra, Hilmi;
El Nasasra, Aref;
Abu-Salman, Amjad;
Abu-Dogosh, Ala;
Weissberg, Itay;
Golan, Yael Ben-Baruch;
Barrett, Orit;
Westreich, Roi;
Aboalhasan, Enis;
Azuri, Joseph;
Hammerman, Ariel;
Arbel, Ronen

Publication type:

Article

Dapagliflozin Versus Sacubitril–Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 325, doi. 10.1007/s40256-021-00506-5

By:

Hammerman, Ariel;
Azuri, Joseph;
Aboalhasan, Enis;
Arbel, Ronen

Publication type:

Article

Dapagliflozin versus empagliflozin in patients with chronic kidney disease.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1227199

By:

Alnsasra, Hilmi;
Tsaban, Gal;
Solomon, Adam;
Khalil, Fouad;
Aboalhasan, Enis;
Azab, Abed N.;
Azuri, Joseph;
Hammerman, Ariel;
Arbel, Ronen

Publication type:

Article

Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 961, doi. 10.1111/dom.14940

By:

Azuri, Joseph;
Hammerman, Ariel;
Aboalhasan, Enis;
Sluckis, Ben;
Arbel, Ronen

Publication type:

Article

The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study.

Published in:

Acta Oncologica, 2015, v. 54, n. 2, p. 164, doi. 10.3109/0284186X.2014.958532

By:

Hammerman, Ariel;
Greenberg-Dotan, Sari;
Battat, Erez;
Feldhamer, Ilan;
Bitterman, Haim;
Brenner, Baruch

Publication type:

Article

Correction to: Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis.

Published in:

2020

By:

Arbel, Ronen;
Aboalhasan, Enis;
Hammerman, Ariel;
Azuri, Joseph

Publication type:

Correction Notice

Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 7, p. 665, doi. 10.1007/s40261-020-00929-z

By:

Arbel, Ronen;
Aboalhasan, Enis;
Hammerman, Ariel;
Azuri, Joseph

Publication type:

Article

Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.

Published in:

PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0176858

By:

Leventer-Roberts, Maya;
Hammerman, Ariel;
Brufman, Ilan;
Hoshen, Moshe;
Braun, Marius;
Ashur, Yaffa;
Lieberman, Nicky;
Balicer, Ran

Publication type:

Article

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis.

Published in:

Breast Journal, 2020, v. 26, n. 10, p. 2096, doi. 10.1111/tbj.13870

By:

Bar-Sela, Gil;
Samih, Yousef;
Yerushalmi, Rinat;
Leviov, Michelle;
Efrat Ben‐Baruch, Noa;
Kuchuk, Iryna;
Tokar, Margarita;
Peretz‐Yablonski, Tamar;
Sonnenblick, Amir;
Soussan‐Gutman, Lior;
Bareket‐Samish, Avital;
Fried, Georgeta;
Paluch‐Shimon, Shani;
Kaufman, Bella;
Hammerman, Ariel;
Liebermann, Nicky;
Stemmer, Salomon M.

Publication type:

Article

Risk sharing or risk shifting? On the development of patient access schemes in the process of updating the national list of health services in Israel.

Published in:

2019

By:

Triki, Noa;
Ash, Nachman;
Porath, Avi;
Birnbaum, Yair;
Greenberg, Dan;
Hammerman, Ariel

Publication type:

journal article

The ESMO-Magnitude of Clinical Benefit Scale for novel oncology drugs: correspondence with three years of reimbursement decisions in Israel.

Published in:

2018

By:

Hammerman, Ariel;
Greenberg-Dotan, Sari;
Feldhamer, Ilan;
Birnbaum, Yair;
Cherny, Nathan I.

Publication type:

journal article

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.

Published in:

Oncologist, 2023, v. 28, n. 6, p. e391, doi. 10.1093/oncolo/oyad061

By:

Icht, Oded;
Leader, Avi;
Batat, Erez;
Yosef, Lilach;
Shochat, Tzippy;
Goldstein, Daniel A;
Dudnik, Elizabeth;
Spectre, Galia;
Raanani, Pia;
Hammerman, Ariel;
Zer, Alona

Publication type:

Article

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.

Published in:

Oncologist, 2017, v. 22, n. 6, p. 694, doi. 10.1634/theoncologist.2016-0455

By:

Goldstein, Daniel A.;
Chen, Qiushi;
Ayer, Turgay;
Chan, Kelvin K. W.;
Virik, Kiran;
Hammerman, Ariel;
Brenner, Baruch;
Flowers, Christopher R.;
Hall, Peter S.

Publication type:

Article

Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study.

Published in:

Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 1, p. 1, doi. 10.1002/dmrr.3355

By:

Tsur, Anat;
Cahn, Avivit;
Israel, Meirav;
Feldhamer, Ilan;
Hammerman, Ariel;
Pollack, Rena

Publication type:

Article

Can Consultation by a Clinical Pharmacist Prevent Morbidity and Mortality in Patients Undergoing Bariatric Surgery?

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 310, doi. 10.3390/jcm13020310

By:

Azran, Carmil;
Dahan, Almog Eliyahu;
Shimoni, Orly;
Dicker, Dror;
Hammerman, Ariel;
Dahan, Arik

Publication type:

Article

Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis.

Published in:

Obesity (19307381), 2023, v. 31, n. 6, p. 1510, doi. 10.1002/oby.23752

By:

Azuri, Joseph;
Hammerman, Ariel;
Aboalhasan, Enis;
Sluckis, Ben;
Arbel, Ronen

Publication type:

Article

Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study.

Published in:

PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138229

By:

Hammerman, Ariel;
Greenberg-Dotan, Sari;
Feldhamer, Ilan;
Bitterman, Haim;
Yerushalmi, Rinat

Publication type:

Article

Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.

Published in:

2015

By:

Shalom, Guy;
Zisman, Devy;
Bitterman, Haim;
Harman-Boehm, Ilana;
Greenberg-Dotan, Sari;
Dreiher, Jacob;
Feldhamer, Ilan;
Moser, Hadas;
Hammerman, Ariel;
Cohen, Yoram;
Cohen, Arnon D

Publication type:

journal article

Systemic Therapy for Psoriasis and the Risk of Herpes Zoster A 500000 Person-year Study.

Published in:

JAMA Dermatology, 2015, v. 151, n. 5, p. 533, doi. 10.1001/jamadermatol.2014.4956

By:

Shalom, Guy;
Zisman, Devy;
Bitterman, Haim;
Harman-Boehm, Ilana;
Greenberg-Dotan, Sari;
Dreiher, Jacob;
Feldhamer, Ilan;
Moser, Hadas;
Hammerman, Ariel;
Cohen, Yoram;
Cohen, Arnon D.

Publication type:

Article

Oral versus subcutaneous semaglutide for prevention of major adverse cardiovascular events: cost per outcome analysis of SUSTAIN-6 and PIONEER-6.

Published in:

Postgraduate Medicine, 2022, v. 134, n. 7, p. 654, doi. 10.1080/00325481.2022.2090794

By:

Hammerman, Ariel;
Moore, Candace Makeda;
Aboalhasan, Enis;
Azuri, Joseph;
Arbel, Ronen

Publication type:

Article

Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.

Published in:

Breast Cancer (13406868), 2025, v. 32, n. 2, p. 286, doi. 10.1007/s12282-024-01652-9

By:

Katz, Daniela;
Feldhamer, Ilan;
Wolff-Sagy, Yael;
Goldvaser, Hadar;
Hammerman, Ariel;
Goldstein, Daniel A.

Publication type:

Article

Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.

Published in:

Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 507, doi. 10.1007/s10549-021-06498-9

By:

Pomerantz, Adi;
Tsoref, Daliah;
Grubstein, Ahuva;
Wadhawker, Sonya;
Rapson, Yael;
Gadiel, Itay;
Goldvaser, Hadar;
Feldhamer, Ilan;
Hammerman, Ariel;
Shochat, Tzipora;
Sharon, Eran;
Kedar, Inbal;
Yerushalmi, Rinat

Publication type:

Article

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.625668

By:

Daher, Sameh;
Lawrence, Yaacov R.;
Dudnik, Elizabeth;
Hanovich, Ekaterina;
Urban, Damien;
Peled, Nir;
Navon, Rossie;
Leibowitz, Raya;
Hammerman, Ariel;
Battat, Erez;
Gottfried, Teodor;
Onn, Amir;
Bar, Jair

Publication type:

Article